CN1172709C - Medicine for treating rheumatalgia - Google Patents
Medicine for treating rheumatalgia Download PDFInfo
- Publication number
- CN1172709C CN1172709C CNB021308411A CN02130841A CN1172709C CN 1172709 C CN1172709 C CN 1172709C CN B021308411 A CNB021308411 A CN B021308411A CN 02130841 A CN02130841 A CN 02130841A CN 1172709 C CN1172709 C CN 1172709C
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- rheumatalgia
- raw materials
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a medicine for treating rheumatalgia, which is medicine mainly for treating rheumatalgia and a Chinese patent medicine using Chinese herbal medicine as raw materials. The medicine uses atractylodes rhizome, common monkshood mother root, Chinese angelica, chuanxiong rhizome, frankincense, myrrh and clove as raw materials; the raw materials are dried, crushed, and placed into a pill making machine to be pressed into water pills of which the sizes are about those of mung bean granules. The medicine can effectively treat rheumatalgia and can treat and radically cure rheumatalgia and rheumatic diseases; the medicine also has good therapeutic effects on other kinds of gout.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of rheumatalgia, is a kind of medicine of main treatment rheumatalgia, is to be the Chinese patent medicine of raw material with the Chinese herbal medicine.
Background technology
Rheumatalgia and rheumatism are a kind of commonly encountered diseases, and be many because of the damp and hot wind-dryness of experiencing, and the cold-damp mist is attacked due to the human body, and ancient times, well-known doctor's Zhang Zhongjing was mentioned " the most all over the body pain of patient, this rheumatism " in " Medical Treasures of the Golden Chamber ".The generation of patient's skin and joint is tingle during morbidity, pain is red and swollen, and the whole body is uncomfortable, lassitude, and brothers forget oneself, and vim and vigour are weak, and are obstinate unusual, the difficult healing.Be referred to as arthromyodynia, be divided into five types of migratory arthralgia, arthralgia due to cold, arthralgia chiefly caused by damp pathogen damp arthralgia and migratory arthralgias again.Current, the Western medicine antiinflammatory commonly used of treatment rheumatalgia, these Western medicine not only cost an arm and a leg, and toxic and side effects is also higher, can not cure, the relapse rate height.It is the work of always studying that rheumatalgia is treated in utilization Chinese herbal treatment or auxiliary smelting, but present medicine can only alleviate the patient suffering, can not effect a radical cure, and curative effect can not be satisfactory.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of rheumatalgia, can and effect a radical cure rheumatalgia and rheumatism with lower cost treatment, and other gout is also had better curative effect.
Solution of the present invention is according to the rule of the traditional Chinese medical science to rheumatalgia, i.e. the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling, the wind pain relieving of loosing, benefiting qi and nourishing blood, expelling wind and removing dampness, the present invention forms according to above-mentioned rule, can blood circulation promoting and blood stasis dispelling, the wind pain relieving of loosing, expelling wind and removing dampness again can the body resistance strengthening and constitution consolidating, hard masses softening and resolving.Radix Aconiti of the present invention, Rhizoma Chuanxiong and Myrrha expelling pathogenic wind and eliminating dampness, promoting blood circulation and breaking stagnation, warming spleen and stomach for dispelling cold, the wind pain relieving of loosing, detumescence convergence, expelling pus and promoting granulation, warming the meridian and promoting blood circulation; Radix Angelicae Sinensis and Olibanum are enriched blood and are invigorated blood circulation, regulating qi and activating blood, and muscles and tendons relaxing to alleviate pain, blood stasis dispersing and fresh blood promoting, regulating menstruation is moisturized; Heavy dose of Rhizoma Atractylodis that use have blood sugar lowering, promote effects such as row's sodium and potassium, can remove rheumatism, the spleen strengthening and damp drying, loose strongly fragrantly to ward off dirtyly, can go the vomiting and diarrhoea of anemofrigid-damp arthralgia and edema distension and cold-damp; The Flos Caryophylli warming the spleen and stomach, invigorating kidney-YANG, lowering the adverse flow of QI; Have eliminating evil just the wound, set upright and do not stay the evil effect of well curing the disease.
The present invention is the medicine of being made by the following weight proportion raw material
41～61 parts of 41～61 parts of Radix Angelicae Sinensis of 72～92 portions of Radix Aconitis of Rhizoma Atractylodis
19～39 parts of 19～39 parts of Myrrhas of 41～61 parts of Olibanums of Rhizoma Chuanxiong
14.5～34.5 parts of Flos Caryophyllis
The weight proportion of each raw material of formula optimization of the present invention is
44～58 parts of 44～58 parts of Radix Angelicae Sinensis of 75～89 portions of Radix Aconitis of Rhizoma Atractylodis
22～36 parts of 22～36 parts of Myrrhas of 44～58 parts of Olibanums of Rhizoma Chuanxiong
17.5～31.5 parts of Flos Caryophyllis
The weight proportion of best each raw material of prescription of the present invention is
51 parts of 51 parts of Radix Angelicae Sinensis of 82 portions of Radix Aconitis of Rhizoma Atractylodis
29 parts of 29 parts of Myrrhas of 51 parts of Olibanums of Rhizoma Chuanxiong
24.5 parts of Flos Caryophyllis
Described medicine is a said medicine on any pharmaceutics.
The present invention can be made into watered pill medicine grain, method for making is to get Rhizoma Atractylodis, Radix Aconiti, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Olibanum, Myrrha and Flos Caryophylli drying and crushing to 120～200 order fine powders, adds 20 grams by per 100 gram fine powders and practices honey and 10 gram flour, adds water again, stir, make the dough shape, be pressed into the watered pill medicine grain of Semen phaseoli radiati grain size in the pellet processing machine of packing into, the dry again moisture content of removing, every medicine nearly weighs 0.1g, every day secondary, each 50, it is for oral administration that yellow wine send down.
Clinical drug of the present invention uses the result to show that following advantage is arranged;
1, the Chinese herbal medicine each component selected for use of the present invention meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment rheumatalgia of the Chinese medicine of respectively distinguishing the flavor of, and does not have chemical sweeting agent, and harmless, safety of medicine is reliable.
2, the present invention is easy to use, rich in proteins in the medicine, and glucose, phlegmatic temperament, organic acid, fatty oil, vitamin is beneficial to absorption of human body, health invigorating, and hundred yuan of required expense less thaies, it is low to cure cost.
3, the present invention can treat and effect a radical cure rheumatalgia effectively, and other rheumatism is also had the effect of better curative effect function, has improved patient's life quality and the time greatly, and higher healing rehabilitation efficacy is arranged.
For showing the therapeutic effect of medicine of the present invention to rheumatism, the present invention is as follows through clinical test results; Treat various rheumatalgia patient's 70 examples, radical cure rehabilitation 44 examples, produce effects 12 examples, effective 9 examples, invalid 5 examples, effective percentage reaches more than 90%.Treat other rheumatism 40 examples, radical cure rehabilitation 25 examples, produce effects 6 examples, effective 3 examples, invalid 6 examples, effective percentage reaches more than 80%.
The specific embodiment
Take by weighing raw material by following proportioning;
Rhizoma Atractylodis 82g Radix Aconiti 51g Radix Angelicae Sinensis 51g
Rhizoma Chuanxiong 51g Olibanum 29g Myrrha 29g
Flos Caryophylli 24.5g
The present invention can be made into watered pill medicine grain, method for making is to get Rhizoma Atractylodis, Radix Aconiti, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Olibanum, Myrrha and Flos Caryophylli drying and crushing to 120～200 order fine powders, adds 20 grams by per 100 gram fine powders and practices honey and 10 gram flour, adds water again, stir, make the dough shape, be pressed into the watered pill medicine grain of Semen phaseoli radiati grain size in the pellet processing machine of packing into, the dry again moisture content of removing, every medicine nearly weighs 0.1g, every day secondary, each 50, it is for oral administration that yellow wine send down.
Claims (3)
1, a kind of medicine for the treatment of rheumatalgia is characterized in that it is made up of following components in weight percentage:
41～61 parts of 41～61 parts of Radix Angelicae Sinensis of 72～92 portions of Radix Aconitis of Rhizoma Atractylodis
19～39 parts of 19～39 parts of Myrrhas of 41～61 parts of Olibanums of Rhizoma Chuanxiong
14.5～34.5 parts of Flos Caryophyllis.
2, a kind of medicine for the treatment of rheumatalgia according to claim 1, wherein the weight proportion of each component is:
44～58 parts of 44～58 parts of Radix Angelicae Sinensis of 75～89 portions of Radix Aconitis of Rhizoma Atractylodis
22～36 parts of 22～36 parts of Myrrhas of 44～58 parts of Olibanums of Rhizoma Chuanxiong
17.5～31.5 parts of Flos Caryophyllis.
3, a kind of medicine for the treatment of rheumatalgia according to claim 1, wherein the weight proportion of each component is:
51 parts of 51 parts of Radix Angelicae Sinensis of 82 portions of Radix Aconitis of Rhizoma Atractylodis
29 parts of 29 parts of Myrrhas of 51 parts of Olibanums of Rhizoma Chuanxiong
24.5 parts of Flos Caryophyllis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021308411A CN1172709C (en) | 2002-10-14 | 2002-10-14 | Medicine for treating rheumatalgia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021308411A CN1172709C (en) | 2002-10-14 | 2002-10-14 | Medicine for treating rheumatalgia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1413650A CN1413650A (en) | 2003-04-30 |
| CN1172709C true CN1172709C (en) | 2004-10-27 |
Family
ID=4746479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021308411A Expired - Fee Related CN1172709C (en) | 2002-10-14 | 2002-10-14 | Medicine for treating rheumatalgia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1172709C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107714866A (en) * | 2017-12-07 | 2018-02-23 | 商子海 | A kind of Chinese medicine ointment for treating orthopaedics disease |
-
2002
- 2002-10-14 CN CNB021308411A patent/CN1172709C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1413650A (en) | 2003-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101053632A (en) | Traditional Chinese medicine for treating thromboangitis obliterans | |
| CN101125166A (en) | External-applied traditional Chinese medicine for treating rheumatism | |
| CN102008610B (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN1861155A (en) | Method for preparing traditional Chinese medicine for treating rheumatism and rheumatoid disease, and said medicine thereby | |
| CN104758743A (en) | Traditional Chinese medicine foot fumigating powder for treating rheumatism as well as preparation method and using method thereof | |
| CN1709314A (en) | Medicinal liquor for treating rheumatic arthrolithiasis and its preparing method | |
| CN1478525A (en) | Medicated wine for treating traumatic injury | |
| CN1172709C (en) | Medicine for treating rheumatalgia | |
| CN1709458A (en) | Medicine for treating coronary clisease | |
| CN1824103A (en) | External use medicine for treating knocks and falls and bone joining | |
| CN1223132A (en) | Medicine for curing dermatosis | |
| CN101125180A (en) | Traditional Chinese medicine for curing rheumatism | |
| CN1194728C (en) | Pellet capable of curing infantile anorexia and convulsion | |
| CN1312085A (en) | Dermatosis treating medicine | |
| CN1177605C (en) | Pill for treating rheumatic carditis | |
| CN1241580C (en) | Medicinal composition for treating hypersteogeny | |
| CN1172710C (en) | Pill capable of treating hepatogastric disease | |
| CN1190224C (en) | Medicine for treating stomach trouble | |
| CN1305508C (en) | Pill for treating coronary heart disease | |
| CN1168482C (en) | Chinese medicine composition for treating enteritis | |
| CN1164324C (en) | Chiese medicine preparation for treating parenchyma pain | |
| CN103055246A (en) | Bone impediment pain-eliminating pill | |
| CN1840146A (en) | Medicament for treating vitiligo | |
| CN1194729C (en) | External use medicine for curing piles | |
| CN106109944A (en) | A kind of Chinese medicine composition treating oral ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041027 Termination date: 20121014 |